alexa In-Vitro Release and Pharmacokinetics of Anti-tubercle Drug Ethionamide in Healthy Male Subjects

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

In-Vitro Release and Pharmacokinetics of Anti-tubercle Drug Ethionamide in Healthy Male Subjects

thionamide is an isonicotinic acid derivative of thioamide class. It is the second line orally administered drug used in the treatment of clinical tuberculosis that has failed to respond to adequate first line therapy. Ethionamide is often combined with other anti tuberculous agents for the treatment of multidrug resistant organisms. Ethionamide is active against tubercle bacilli that are growing with in human macrophages.

Ahmad M, Madni AU, Usman M (2009) In-Vitro Release and Pharmacokinetics of Anti-tubercle Drug Ethionamide in Healthy Male Subjects. J Bioanal Biomed 1: 046-049. doi: 10.4172/1948-593X.1000010

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords